Immune Engineering -
from Molecules to Therapeutic Approaches

Stadthaus Ulm
December 1, 2023

2nd Joint Meeting of GBM & BioPharma Cluster South Germany


Dear colleagues and friends,

Following our successful joint event on RNA Therapeutics last year, we will continue our collaboration and would like to invite you to the 2nd joint event of the BioPharma Cluster South Germany and the German Society for Biochemistry and Molecular Biology (GBM).

This year, we will focus on translational research in immune engineering, covering basic research, drug development and manufacturing, and clinical application. The patients' perspective will also be addressed in the panel discussion. The target audience is researchers, developers and engineers from industry and academia, young scientists, physicians, and anyone who would like to have a look at the big picture of what we do for patients with our contributions in research, engineering, manufacturing, analytical testing and clinical application.



At the end of the event, we offer all participants the opportunity for exchange and networking.

We would be pleased to welcome you on December 1st at the “Stadthaus” in Ulm at the Münster Platz hosting Ulm´s Christmas Market at that time and look forward to an inspiring meeting and networking event!

Uwe Bücheler
(Senior Advisor Biopharmaceuticals, Boehringer Ingelheim; Chairman of the BioPharma Cluster South Germany)


13:00 - 14:30
from University

Matthias Feige /Technical University Munich
Targeting and engineering immune cell communication for novel therapies

Dirk Busch /Technical University Munich
Advanced T cell receptor engineering for repertoire analysis and cell therapies

Andrea Schmidts /Technical University Munich
Engineering resilient chimeric antigen receptor (CAR)-T cell therapies

14:30 - 14:45 Coffee Break

14:45 - 15:45
from Industry

Process Development and Supply of Biopharmaceuticals:

Moderation: Uwe Bücheler/Boehringer Ingelheim

Ann-Cathrin Leroux /Sartorius
Cell Line Development

Christiane Bardroff /Rentschler Biopharma
Drug Substance and Process Development  

Jörg Zimmermann /Vetter
Drug product and Process Development

Stefan Ottmar Fügenschuh /Teva Biotech
Large Scale Manufacturing of Biopharmaceuticals

15:45 - 16:30
Clinical Applications

Stephan Stilgenbauer /University Hospital Ulm
From Biology to Targeted Therapy in Cancer

16:30 - 17:00 Coffee Break

17:00 - 18:00
Panel Discussion
Translation zu Ende gedacht - Was brauchen und nützt Patienten?

(in German)

Uwe Bücheler (BioPharma Cluster)
Stephan Stilgenbauer (Oncology)
Klaus-Michael Debatin (Rare Diseases)
Tanja Vetter, Norman Roßberg (alle Patientenbeirat Comprehensive Cancer Center Ulm)

(Moderation: Dorothee Ambrosius (Senior Advisor Biopharma /Laupheim)

18:00 - 20:00
Networking with fingerfood



The registration & participation is free!

Registration deadline: November 24


Participation in the conference is free of charge but the number of places is limited.
Therefore, we kindly ask you to cancel your participation in time if you find that you will not be able to  attend, in order to allow other interested persons to participate.



Participants are expected to book and pay for their own accommodation and travel expenses.

We recommend booking via online portals such as or


Stadthaus Ulm
Münsterplatz 50
Office: Münsterplatz 2
89073 Ulm

How to get there?

Organization & Contact


BioPharma Cluster
South Germany e.V.

Olgastr. 95-101
89073 Ulm

Phone: +49 731 173225


Meeting Secretariat

Gesellschaft für Biochemie
und Molekularbiologie e.V.

Mörfelder Landstr. 125
60598 Frankfurt am Main

Phone: +49 69 660567-0